ROBITUSSIN CHESTY COUGH MEDICINE Oral solution Ref.[50001] Active ingredients: Guaifenesin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.

4.1. Therapeutic indications

Expectorant for the treatment of coughs.

4.2. Posology and method of administration

Oral administration.

Adults, the elderly and children over 12 years

One 10ml measure up to four times daily.

Children under 12 years

Do not use.

4.9. Overdose

In case of overdose, discontinue use and seek professional assistance immediately.

Signs and Symptoms associated with an overdose of Guaifenesin: Nausea and vomiting

Treatment: Appropriate supportive therapy dependent upon individual response to the preparation.

6.3. Shelf life

100ml bottles: 27 months.

250ml bottles: 36 months.

6.4. Special precautions for storage

Do not store above 25°C.

Keep out of the sight and reach of children.

6.5. Nature and contents of container

PET bottles containing 100ml or 250ml with PET lined PP/HDPE screw caps.

A clear polypropylene measuring cap is also included.

6.6. Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.